:Genetics

A new report in the genetic test of the agency of HHS for calls of the research and the quality of medical cares for the creation of public databases improved of the sanitary control and the technologies of the information of the health to monitor the use of gene-base tests and its impact in patient results.

Financed for centers for the control and prevention of diseases, for the intitled report, the infrastructure to monitor the use and the results of Gene-base applications: An evaluation, found that the current systems of monitoring of the public health lack the capacity to monitor the use or the results of tests and gene-base treatments. The authors of the report had identified diverse limitations of existing potential solution and databases to surpass these limitations.

The investigators had agreed that the development of gene-base tests is taking the advantage to the evaluation of its exactness and clinical utility. the Gene-base tests can, in some cases, to help to in advance make the diagnosis of an illness, to improve the prediction of the risk, and the therapies of the target for both the traditional gene-base clutters as well as common crnicas illnesses. However, since all the tests and treatments are not waited to have the same amount of benefit, the connoisseurs had said that it is important to distinguish beneficial tests and treatments of that they have almost no benefit or that they can exactly harm the public.

Many gene-base tests are only recommended for peoples with determined risk factors. For example, the services that preventive of the E.U the work group recommends doctors of the primary attention must only consult women of high risk so that the genetic assistance and to test detects the genetic mutations associates with the ovarianos chest or cancers. The work group recommends that the women who do not have familiar antecedents of the chest or the ovariano cancer and are little susceptveis to test the positive for the mutations do not have to be consulted for the test, because she has potential harms involved in the genetic test that includes resulted of the analysis falsifies-positive. Equally, the work group recommends of meeting to the routine genetic election in the general population for hemocromatose hereditary, a genetic illness that makes with that the body absorbs and stores iron too much.

The best capacities of the monitorao would help to identify that gene-they had based tests they improve resulted patient and they are cost-effective, the joined investigators. In 2009, the world-wide market for the gene-base test is waited to alcangar $12,5 billion.

More than 1,000 gene-base tests are now available to the consumers through its physicians, and they are not waited to become in a next future available. Some of these tests are introduced in the market directly the consumers. The commission of federal commerce emitted an alert one of the consumer in the familiar genetic test and stirs up consumers to be skeptical of the claims made for the company that are introducing in the market these tests directly to the consumers. AHRQ recommends patients consults with its physicians to evaluate its factors of risk and to determine its necessity for the genetic test.

The report is accessible on-line.

http://www.ahrq.gov